{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:49:59Z","timestamp":1781128199327,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1124\/dmd.119.087734","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T22:19:01Z","timestamp":1564697941000},"page":"1013-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1)"],"prefix":"10.1016","volume":"47","author":[{"given":"Andaleeb","family":"Sajid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natarajan","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Lusvarghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrooz","family":"Vahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf E.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh V.","family":"Ambudkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.087734_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aav7102","article-title":"Structural insight into substrate and inhibitor discrimination by human P-glycoprotein","volume":"363","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1124\/dmd.119.087734_bib2","doi-asserted-by":"crossref","first-page":"E1973","DOI":"10.1073\/pnas.1717044115","article-title":"Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1","volume":"115","author":"Alam","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.119.087734_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.119.087734_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2005.10.010","article-title":"The power of the pump: mechanisms of action of P-glycoprotein (ABCB1)","volume":"27","author":"Ambudkar","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.087734_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84","article-title":"PharmGKB summary: cyclosporine and tacrolimus pathways","volume":"23","author":"Barbarino","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.119.087734_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/jo101865y","article-title":"Thionations using a P4S10-pyridine complex in solvents such as acetonitrile and dimethyl sulfone","volume":"76","author":"Bergman","year":"2011","journal-title":"J Org Chem"},{"key":"10.1124\/dmd.119.087734_bib7","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1039\/C7NJ04032F","article-title":"1,1-Difluoro-3-aryl(heteroaryl)-1H-pyrido[1,2-c][1,3,5,2]oxadiazaborinin-9-ium-1-uides: synthesis; structure; and photophysical, electrochemical, and BSA-binding studies","volume":"42","author":"Bonacorso","year":"2018","journal-title":"New J Chem"},{"key":"10.1124\/dmd.119.087734_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-642-14541-4_6","article-title":"P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations","volume":"201","author":"Cascorbi","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.bcp.2004.07.009","article-title":"Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder","volume":"68","author":"Chearwae","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib10","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1074\/jbc.272.9.5974","article-title":"Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins","volume":"272","author":"Chen","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.087734_bib11","doi-asserted-by":"crossref","first-page":"e82463","DOI":"10.1371\/journal.pone.0082463","article-title":"Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1) (Abstract)","volume":"8","author":"Chufan","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/dmd.119.087734_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.acr.2014.10.003","article-title":"Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies","volume":"125","author":"Chufan","year":"2015","journal-title":"Adv Cancer Res"},{"key":"10.1124\/dmd.119.087734_bib13","doi-asserted-by":"crossref","first-page":"18110","DOI":"10.1021\/bi981992c","article-title":"Identification of the cyclosporin-binding site in P-glycoprotein","volume":"37","author":"Demeule","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.119.087734_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1139\/o99-011","article-title":"Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites","volume":"77","author":"Demeule","year":"1999","journal-title":"Biochem Cell Biol"},{"key":"10.1124\/dmd.119.087734_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5414\/CPP42701","article-title":"Pharmacokinetics of immunosuppressants: a perspective on ethnic differences","volume":"42","author":"Dirks","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087734_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/jo00055a020","article-title":"Preparation of [D-cysteine]8-cyclosporin via intramolecular sulfur transfer reaction","volume":"58","author":"Eberle","year":"1993","journal-title":"J Org Chem"},{"key":"10.1124\/dmd.119.087734_bib17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/mol.104.001701","article-title":"Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A","volume":"67","author":"Ejendal","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002320001020","article-title":"Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system","volume":"173","author":"Gribar","year":"2000","journal-title":"J Membr Biol"},{"key":"10.1124\/dmd.119.087734_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tibs.2009.07.009","article-title":"Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1","volume":"35","author":"Gutmann","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/dmd.119.087734_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer\u2019s disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib21","first-page":"F756","article-title":"Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues","volume":"270","author":"Jett\u00e9","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.119.087734_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(91)90418-S","article-title":"Fluorescent membrane probes incorporating dipyrrometheneboron difluoride fluorophores","volume":"198","author":"Johnson","year":"1991","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.119.087734_bib23","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3390\/pharmaceutics8020012","article-title":"Evaluation of P-glycoprotein inhibitory potential using a rhodamine 123 accumulation assay (Abstract)","volume":"8","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1124\/dmd.119.087734_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.119.087734_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1389200023337630","article-title":"Review: metabolism of immunosuppressant drugs","volume":"3","author":"Kelly","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.119.087734_bib26","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1074\/jbc.M010044200","article-title":"Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates","volume":"276","author":"Kerr","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.087734_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1126\/science.aar7389","article-title":"Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation","volume":"359","author":"Kim","year":"2018","journal-title":"Science"},{"key":"10.1124\/dmd.119.087734_bib28","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acs.biochem.6b01245","article-title":"Differential coupling of binding, ATP hydrolysis, and transport of fluorescent probes with P-glycoprotein in lipid nanodiscs","volume":"56","author":"Li","year":"2017","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.119.087734_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjp.0702807","article-title":"The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein","volume":"128","author":"Martin","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0026-895X(24)26442-7","article-title":"Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule","volume":"57","author":"Masereeuw","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.113.210641","article-title":"Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule","volume":"348","author":"Miller","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.087734_bib32","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1021\/bi026075s","article-title":"Evidence for the role of glycosylation in accessibility of the extracellular domains of human MRP1 (ABCC1)","volume":"41","author":"M\u00fcller","year":"2002","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.119.087734_bib33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2967\/jnumed.108.059162","article-title":"Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans","volume":"50","author":"Muzi","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1124\/dmd.119.087734_bib34","doi-asserted-by":"crossref","first-page":"47145","DOI":"10.1039\/C6RA08625J","article-title":"Super\/hyperhalogen aromatic heterocyclic compounds","volume":"6","author":"Naaresh Reddy","year":"2016","journal-title":"RSC Advances"},{"key":"10.1124\/dmd.119.087734_bib35","doi-asserted-by":"crossref","first-page":"e1600001","DOI":"10.1126\/sciadv.1600001","article-title":"Global marine pollutants inhibit P-glycoprotein: environmental levels, inhibitory effects, and cocrystal structure (Abstract)","volume":"2","author":"Nicklisch","year":"2016","journal-title":"Sci Adv"},{"key":"10.1124\/dmd.119.087734_bib36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-010-0074-1","article-title":"St. John\u2019s Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier","volume":"27","author":"Ott","year":"2010","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.087734_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-006-0357-8","article-title":"Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins","volume":"60","author":"Pawarode","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/acs.biochem.5b01064","article-title":"Human-mouse chimeras with normal expression and function reveal that major domain swapping is tolerated by P-glycoprotein (ABCB1)","volume":"55","author":"Pluchino","year":"2016","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.119.087734_bib39","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1021\/bi973045u","article-title":"Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state","volume":"37","author":"Ramachandra","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.119.087734_bib40","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporin A and FK506","volume":"268","author":"Saeki","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.087734_bib41","doi-asserted-by":"crossref","first-page":"e0204693","DOI":"10.1371\/journal.pone.0204693","article-title":"Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1)","volume":"13","author":"Sajid","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/dmd.119.087734_bib42","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J Mol Graph Model"},{"key":"10.1124\/dmd.119.087734_bib43","first-page":"F46","article-title":"P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules","volume":"268","author":"Schramm","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.119.087734_bib44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.3457471","article-title":"Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification","volume":"232","author":"Shen","year":"1986","journal-title":"Science"},{"key":"10.1124\/dmd.119.087734_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/dmd.111.042721","article-title":"Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells","volume":"40","author":"Shukla","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087734_bib46","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/mp2001022","article-title":"Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters","volume":"8","author":"Shukla","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.087734_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1124\/dmd.119.087734_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ab.2013.02.018","article-title":"Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters","volume":"437","author":"Strouse","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.119.087734_bib49","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1107\/S1399004715000978","article-title":"Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein","volume":"71","author":"Szewczyk","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/dmd.119.087734_bib50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbamem.2017.10.028","article-title":"Comparison of mechanistic transport cycle models of ABC exporters","volume":"1860","author":"Sz\u00f6ll\u0151si","year":"2018","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1124\/dmd.119.087734_bib51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1023\/A:1016019010339","article-title":"Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein","volume":"13","author":"Tanaka","year":"1996","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.087734_bib52","doi-asserted-by":"crossref","first-page":"230386","DOI":"10.1155\/2012\/230386","article-title":"Cyclosporine: a review","volume":"2012","author":"Tedesco","year":"2012","journal-title":"J Transplant"},{"key":"10.1124\/dmd.119.087734_bib53","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.119.087734_bib54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1124\/dmd.119.087734_bib55","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/anie.200702070","article-title":"The chemistry of fluorescent bodipy dyes: versatility unsurpassed","volume":"47","author":"Ulrich","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/dmd.119.087734_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2017.07.014","article-title":"Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency","volume":"143","author":"Vahedi","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.087734_bib57","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1038\/s41598-018-30984-8","article-title":"Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein","volume":"8","author":"Vahedi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.119.087734_bib58","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1021\/jacs.7b05878","article-title":"Rational design of in vivo tau tangle-selective near-infrared fluorophores: expanding the BODIPY universe","volume":"139","author":"Verwilst","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.119.087734_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.103.054197","article-title":"Interaction of antiepileptic drugs with human P-glycoprotein in vitro","volume":"307","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.087734_bib60","first-page":"123","article-title":"Cyclosporine and analogues--isolation and synthesis--mechanism of action and structural requirements for pharmacological activity","volume":"50","author":"Wenger","year":"1986","journal-title":"Fortschr Chem Org Naturst"},{"issue":"2 Suppl 2","key":"10.1124\/dmd.119.087734_bib61","first-page":"313","article-title":"Cyclosporine: conformation and analogues as tools for studying its mechanism of action","volume":"20","author":"Wenger","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1124\/dmd.119.087734_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.17219\/acem\/35254","article-title":"The effect of P-glycoprotein inhibition and activation on the absorption and Serum levels of cyclosporine and tacrolimus in rats","volume":"25","author":"Yigitaslan","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1124\/dmd.119.087734_bib63","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/acs.bioconjchem.7b00211","article-title":"Synthesis of BODIPY-peptide conjugates for fluorescence labeling of EGFR overexpressing cells","volume":"28","author":"Zhao","year":"2017","journal-title":"Bioconjug Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407661X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407661X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.087734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:48:14Z","timestamp":1739904494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562407661X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S009095562407661X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.087734","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1)","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.087734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}